Pages that link to "Q52832711"

The following pages link to The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. (Q52832711):

Displayed 50 items.

• DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis (Q24316141) ‎ (← links)
• Analysis of the genome to personalize therapy for melanoma (Q24601008) ‎ (← links)
• The PI3K pathway as drug target in human cancer (Q24632283) ‎ (← links)
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways (Q24656128) ‎ (← links)
• Chemoresistance in human ovarian cancer: the role of apoptotic regulators (Q24791433) ‎ (← links)
• Pharmacodynamic Biomarker Development for PI3K Pathway Therapeutics (Q26766292) ‎ (← links)
• Targeting RTK Signaling Pathways in Cancer (Q26781278) ‎ (← links)
• PI3K and AKT: Unfaithful Partners in Cancer (Q26781367) ‎ (← links)
• Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies (Q26829652) ‎ (← links)
• Diverse mechanisms of AKT pathway activation in human malignancy (Q26851604) ‎ (← links)
• Will kinase inhibitors make it as glioblastoma drugs? (Q27012684) ‎ (← links)
• Phosphoinositides: tiny lipids with giant impact on cell regulation (Q27012953) ‎ (← links)
• Two membrane-associated tyrosine phosphatase homologs potentiate C. elegans AKT-1/PKB signaling (Q27315422) ‎ (← links)
• Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic (Q27824826) ‎ (← links)
• Oncogenic mutations of PIK3CA in human cancers (Q28284802) ‎ (← links)
• PI3K/PTEN signaling in angiogenesis and tumorigenesis (Q28383083) ‎ (← links)
• Targeting the phosphoinositide 3-kinase pathway in cancer (Q29615809) ‎ (← links)
• Targeting PI3K signalling in cancer: opportunities, challenges and limitations (Q29617685) ‎ (← links)
• Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase (Q30156937) ‎ (← links)
• The determinants of head and neck cancer: Unmasking the PI3K pathway mutations (Q30365726) ‎ (← links)
• Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure (Q30388270) ‎ (← links)
• Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA (Q30528973) ‎ (← links)
• Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells. (Q31094570) ‎ (← links)
• A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene (Q33436440) ‎ (← links)
• Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer (Q33554443) ‎ (← links)
• Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells (Q33653016) ‎ (← links)
• A potential role for intragenic miRNAs on their hosts' interactome. (Q33710067) ‎ (← links)
• A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance (Q33769618) ‎ (← links)
• The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors (Q33770769) ‎ (← links)
• Caffeic acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathways (Q33800268) ‎ (← links)
• In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine (Q33888833) ‎ (← links)
• Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome (Q33915396) ‎ (← links)
• Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency (Q33923893) ‎ (← links)
• Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. (Q33956668) ‎ (← links)
• Role of phosphatidylinositol 3-kinase in friend spleen focus-forming virus-induced erythroid disease (Q33964125) ‎ (← links)
• Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer (Q33967933) ‎ (← links)
• Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma (Q33968053) ‎ (← links)
• Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. (Q33980438) ‎ (← links)
• In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT. (Q34037704) ‎ (← links)
• Constitutive AKT activation in follicular lymphoma (Q34037865) ‎ (← links)
• Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients (Q34042341) ‎ (← links)
• Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha (Q34100548) ‎ (← links)
• PI3K: from the bench to the clinic and back (Q34195495) ‎ (← links)
• Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways (Q34252516) ‎ (← links)
• The class I PI3K/Akt pathway is critical for cancer cell survival in dogs and offers an opportunity for therapeutic intervention (Q34286759) ‎ (← links)
• Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression (Q34402615) ‎ (← links)
• Phosphoinositide 3-kinase controls early and late events in mammalian cell division (Q34410971) ‎ (← links)
• Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues (Q34422523) ‎ (← links)
• Adiponectin and cancer: a systematic review (Q34506490) ‎ (← links)
• Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma (Q34586019) ‎ (← links)